Bottom line
KMKCX vs VPMCX: the short answer
KMKCX (Kinetics Market Opportunities Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds.
But VPMCX is far broader, holding 173 positions to 1 for KMKCX, so beyond the top names it adds exposure KMKCX doesn't have.
VPMCX is cheaper at 0.35% vs 2.15% — a difference of $180 a year per $10,000 invested.
Over five years, KMKCX returned +18.6% a year vs +14.3% for VPMCX.
Updated Nov 19, 2026
KMKCX vs VPMCX side by side
| KMKCX | VPMCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Kinetics Mutual | Vanguard |
| Category | Large Blend | Large Blend |
| Expense ratio | 2.15% | 0.35% |
| Annual cost per $10k | $215 | $35 |
| 10-yr cost on $10k (prospectus) | $2,745 | $443 |
| Max front load | 0% | 0% |
| 12b-1 fee | 1% | 0% |
| 1-yr return | −4.8% | +29.9% |
| 5-yr return (annualized) | +18.6% | +14.3% |
| 10-yr return (annualized) | +18.0% | +15.2% |
| Best quarter | +46.0% | +17.3% |
| Worst quarter | −21.6% | −20.2% |
| Net assets (fund) | $302.7M | $96.1B |
| Number of holdings | 1 | 173 |
| Portfolio turnover | 4% | 11% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
KMKCX and VPMCX share none of their top holdings.
KMKCX top 10
- Kinetics Market Opport — 100.01%
VPMCX top 10
- Micron Technology Inc — 13.50%
- Intel Corp — 6.80%
- Eli Lilly & Co — 6.76%
- KLA Corp — 3.85%
- Alphabet Inc — 3.52%
- AstraZeneca PLC — 2.35%
- NVIDIA Corp — 2.33%
- Amazon.com Inc — 2.05%
- Tesla Inc — 1.89%
- Biogen Inc — 1.88%
FAQ
What is the difference between KMKCX and VPMCX?
KMKCX (Kinetics Market Opportunities Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds. But VPMCX is far broader, holding 173 positions to 1 for KMKCX, so beyond the top names it adds exposure KMKCX doesn't have.
Which is cheaper, KMKCX or VPMCX?
VPMCX has the lower expense ratio (0.35%).
Should I own both KMKCX and VPMCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.